PLASMA ENDOTHELIN-1 LEVELS IN OBESE HYPERTENSIVE AND NORMOTENSIVE MEN

被引:110
作者
FERRI, C [1 ]
BELLINI, C [1 ]
DESIDERI, G [1 ]
DIFRANCESCO, L [1 ]
BALDONCINI, R [1 ]
SANTUCCI, A [1 ]
DEMATTIA, G [1 ]
机构
[1] UNIV LAQUILA, DEPT INTERNAL MED, I-67100 LAQUILA, ITALY
关键词
D O I
10.2337/diabetes.44.4.431
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma endothelin-l (ET-1) levels were studied in 15 obese hypertensive (mean age 48.5 +/- 3.9 years) and 15 obese normotensive men (mean age 49.5 +/- 3.6 years) before and after weight loss due to an 800 kcal/day diet lasting 12 weeks. Circulating peptide concentrations were also assessed in nonobese hypertensive (n = 11) and normotensive men (n = 12). Baseline plasma ET-1 levels were similar in obese hypertensive (0.87 +/- 0.22 pg/ml) and obese normotensive men (0.91 +/- 0.30 pg/ml). In seven obese hypertensive men, caloric restriction normalized blood pressure levels (systolic: from 166.6 +/- 8.1 to 145.0 +/- 6.3 mmHg, P < 0.0001; diastolic: from 106.6 +/- 5.1 to 89.1 +/- 2.0 mmHg, p < 0.0001) and decreased body mass index (BMI) (from 33.4 +/- 1.6 to 29.6 +/- 2.1 kg/m(2), P < 0.002) and plasma ET-L levels (from 0.93 +/- 0.21 to 0.64 +/- 0.26 pg/ml, P < 0.05). In the remaining obese hypertensive men (n = 8), blood pressure levels were not normalized by caloric restriction despite a significant decrease of BMI and plasma ET-1 levels (from 0.83 +/- 0.23 to 0.60 +/- 0.16 pg/ml, P +/- 0.04). Weight loss also significantly decreased BMI and ET-1 (from 0.91 +/- 0.30 to 0.65 +/- 0.19 pg/ml, P +/- 0.01) in obese normotensive men. Baseline ET-1 and fasting insulin levels were significantly correlated in obese hypertensive (r = 0.518, P +/- 0.05) and obese normotensive men (r = 0.535, P < 0.04). Changes in fasting insulin levels correlated with corresponding changes in plasma ET-1 levels after weight loss in both obese hypertensive Cr = 0.558, P < 0.04) and obese normotensive men (r = 0.596, P < 0.02). Moreover, plasma peptide levels were significantly higher (P < 0.02) in obese hypertensive and obese normotensive men than in nonobese normotensive men (0.58 +/- 0.28 pg/ml). In conclusion, this study shows that plasma ET-I concentrations are increased in human obesity. The increase could depend on fasting insulin concentrations, abnormal peptide clearance, or both, Hypertension does Plasma not influence the behavior of plasma ET-1 levels in obese men.
引用
收藏
页码:431 / 436
页数:6
相关论文
共 35 条
[1]   GROWTH-FACTOR ACTIVITY OF ENDOTHELIN ON VASCULAR SMOOTH-MUSCLE [J].
BOBIK, A ;
GROOMS, A ;
MILLAR, JA ;
MITCHELL, A ;
GRINPUKEL, S .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (03) :C408-C415
[2]  
Cohen Richard A., 1993, Circulation, V87, pV67
[3]   A SENSITIVE RADIOIMMUNOASSAY MEASURING ENDOTHELIN-LIKE IMMUNOREACTIVITY IN HUMAN PLASMA - COMPARISON OF LEVELS IN PATIENTS WITH ESSENTIAL-HYPERTENSION AND NORMOTENSIVE CONTROL SUBJECTS [J].
DAVENPORT, AP ;
ASHBY, MJ ;
EASTON, P ;
ELLA, S ;
BEDFORD, J ;
DICKERSON, C ;
NUNEZ, DJ ;
CAPPER, SJ ;
BROWN, MJ .
CLINICAL SCIENCE, 1990, 78 (03) :261-264
[4]   AN INVITRO HUMAN MUSCLE PREPARATION SUITABLE FOR METABOLIC STUDIES - DECREASED INSULIN STIMULATION OF GLUCOSE-TRANSPORT IN MUSCLE FROM MORBIDLY OBESE AND DIABETIC SUBJECTS [J].
DOHM, GL ;
TAPSCOTT, EB ;
PORIES, WJ ;
DABBS, DJ ;
FLICKINGER, EG ;
MEELHEIM, D ;
FUSHIKI, T ;
ATKINSON, SM ;
ELTON, CW ;
CARO, JF .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (02) :486-494
[5]   ENDOTHELIAL FUNCTION IN HUMAN CORONARY-ARTERIES INVIVO - FOCUS ON HYPERCHOLESTEROLEMIA [J].
DREXLER, H ;
ZEIHER, AM .
HYPERTENSION, 1991, 18 (04) :90-99
[6]  
FERRANNINI E, 1988, PATHOGENESIS NONINSU, P201
[7]  
FERRI C, 1994, HIGH BLOOD PRESS S1, V3, pA23
[8]  
FERRI C, 1994, J HYPERTENS S3, V12, pS127
[9]   EFFECT OF GLUCOSE AND INSULIN ON IMMUNOREACTIVE ENDOTHELIN-1 RELEASE FROM CULTURED PORCINE AORTIC ENDOTHELIAL-CELLS [J].
HATTORI, Y ;
KASAI, K ;
NAKAMURA, T ;
EMOTO, T ;
SHIMODA, S .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (02) :165-169
[10]   INSULIN STIMULATES PRODUCTION AND SECRETION OF ENDOTHELIN FROM BOVINE ENDOTHELIAL-CELLS [J].
HU, RM ;
LEVIN, ER ;
PEDRAM, A ;
FRANK, HJL .
DIABETES, 1993, 42 (02) :351-358